(Q38803429)

6 September 2017

title

KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE. (English)

1 reference

6 September 2017

Jonathan G Leung

4

0 references

Paul Croarkin

object named as

Paul E Croarkin

3

0 references

Susannah J. Tye

object named as

Susannah J Tye

5

0 references

Mark A Frye

6

object named as

Mark A Frye

1 reference

6 September 2017

William V Bobo

1

1 reference

6 September 2017

Jennifer L Vande Voort

2

1 reference

6 September 2017

language of work or name

1 reference

6 April 2016

1 reference

6 September 2017

published in

Depression and Anxiety

1 reference

6 September 2017

volume

33

1 reference

6 September 2017

issue

8

1 reference

6 September 2017

page(s)

698-710

1 reference

New approaches to antidepressant drug discovery: beyond monoamines

6 September 2017

cites work

1 reference

Acceleration and augmentation strategies for treating bipolar depression

21 January 2018

1 reference

Ketamine as a promising prototype for a new generation of rapid-acting antidepressants

21 January 2018

1 reference

Ketamine analgesia, NMDA receptors and the gates of perception

21 January 2018

1 reference

Pharmacokinetics and analgesic effect of ketamine in man.

21 January 2018

1 reference

Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method.

21 January 2018

1 reference

Rave drug tested against depression

21 January 2018

1 reference

Electroconvulsive therapy is a standard treatment; ketamine is not (yet).

21 January 2018

1 reference

Has psychiatry tamed the "ketamine tiger?" Considerations on its use for depression and anxiety

21 January 2018

1 reference

Long-term maintenance with intramuscular ketamine for treatment-resistant bipolar II depression

21 January 2018

1 reference

The use of a series of ketamine infusions in two patients with treatment-resistant depression

21 January 2018

1 reference

Repeated S-ketamine infusions in therapy resistant depression: a case series

21 January 2018

1 reference

A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression.

21 January 2018

1 reference

A word to the wise about ketamine

21 January 2018

1 reference

Ketamine for depression: where do we go from here?

21 January 2018

1 reference

Ketamine for treatment-resistant depression: ready or not for clinical use?

21 January 2018

1 reference

Ketamine for depression: evidence, challenges and promise

21 January 2018

1 reference

Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder

21 January 2018

1 reference

Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression

21 January 2018

1 reference

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

21 January 2018

1 reference

Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.

21 January 2018

1 reference

Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial

21 January 2018

1 reference

Ketamine as a potential treatment for suicidal ideation: a systematic review of the literature

21 January 2018

1 reference

The STAR*D Project results: a comprehensive review of findings.

21 January 2018

1 reference

The long-term natural history of the weekly symptomatic status of bipolar I disorder

21 January 2018

1 reference

A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.

21 January 2018

1 reference

Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

21 January 2018

1 reference

An overview of recent findings of the Stanley Foundation Bipolar Network (Part I).

21 January 2018

1 reference

Relapse and impairment in bipolar disorder

21 January 2018

1 reference

Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder

21 January 2018

1 reference

Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE).

21 January 2018

1 reference

Suicidal behaviour in bipolar disorder: risk and prevention

21 January 2018

1 reference

Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic.

21 January 2018

1 reference

Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.

21 January 2018

1 reference

A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes

21 January 2018

1 reference

Ketamine as a novel treatment for major depressive disorder and bipolar depression: a systematic review and quantitative meta-analysis

21 January 2018

1 reference

Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression

21 January 2018

1 reference

The use of ketamine as an antidepressant: a systematic review and meta-analysis

21 January 2018

1 reference

Efficacy of Ketamine in Bipolar Depression: Systematic Review and Meta-analysis

21 January 2018

1 reference

Ketamine administration in depressive disorders: a systematic review and meta-analysis

21 January 2018

1 reference

Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy

21 January 2018

1 reference

Ketamine as a novel antidepressant: from synapse to behavior

21 January 2018

1 reference

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

21 January 2018

1 reference

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression

21 January 2018

1 reference

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression

21 January 2018

1 reference

Serial infusions of low-dose ketamine for major depression

21 January 2018

1 reference

Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression

21 January 2018

1 reference

Pilot dose-response trial of i.v. ketamine in treatment-resistant depression

21 January 2018

1 reference

Ketamine safety and tolerability in clinical trials for treatment-resistant depression

21 January 2018

1 reference

Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder

21 January 2018

1 reference

A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: efficacy and tolerability

21 January 2018

1 reference

Ketamine and phencyclidine: the good, the bad and the unexpected

21 January 2018

1 reference

Ketamine as a preferred substance of abuse

21 January 2018

1 reference

Potential Risks of Poorly Monitored Ketamine Use in Depression Treatment

21 January 2018

1 reference

Intensive ketamine use for multiple years: A case report

21 January 2018

1 reference

Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study

21 January 2018

1 reference

Ketamine and damage to the urinary tract

21 January 2018

1 reference

Brain damages in ketamine addicts as revealed by magnetic resonance imaging

21 January 2018

1 reference

Alterations in regional homogeneity of resting-state brain activity in ketamine addicts

21 January 2018

1 reference

Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial

21 January 2018

1 reference

The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

21 January 2018

1 reference

Clinical practice. Bipolar disorder--a focus on depression

21 January 2018

1 reference

A randomized controlled trial of intranasal ketamine in major depressive disorder

21 January 2018

1 reference

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial

21 January 2018

1 reference

Concomitant benzodiazepine use attenuates ketamine response: implications for large scale study design and clinical development

21 January 2018

1 reference

Suicide risk in relation to psychiatric hospitalization: evidence based on longitudinal registers

21 January 2018

1 reference

Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration

21 January 2018

1 reference

Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis.

21 January 2018

1 reference

Maintenance electroconvulsive therapy (M-ECT) after acute response: examining the evidence for who, what, when, and how?

21 January 2018

1 reference

Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study

21 January 2018

1 reference

Single-dose ketamine followed by daily D-Cycloserine in treatment-resistant bipolar depression

21 January 2018

1 reference

Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis.

21 January 2018

1 reference

A case of ketamine dependence with discontinuation symptoms.

21 January 2018

1 reference

Prevalence and Patterns of Prescription Drug Misuse among Young Ketamine Injectors

21 January 2018

1 reference

Addressing risks to advance mental health research

21 January 2018

1 reference

Under-reporting of adverse drug reactions : a systematic review

21 January 2018

1 reference

The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

The clinical relevance of changes in the Montgomery-Asberg Depression Rating Scale using the minimum clinically important difference approach

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/DA.22505

1 reference

6 September 2017

1 reference